311 related articles for article (PubMed ID: 17626616)
1. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
[TBL] [Abstract][Full Text] [Related]
2. Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project.
Marseille E; Dandona L; Saba J; McConnel C; Rollins B; Gaist P; Lundberg M; Over M; Bertozzi S; Kahn JG
Health Serv Res; 2004 Dec; 39(6 Pt 2):1993-2012. PubMed ID: 15544641
[TBL] [Abstract][Full Text] [Related]
3. [Longitudinal analysis of technical efficiency of voluntary counseling and testing of HIV in China].
Cheng G; Qian ZH; Hu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):135-40. PubMed ID: 19377617
[TBL] [Abstract][Full Text] [Related]
4. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency.
Dandona L; Sisodia P; Kumar SG; Ramesh YK; Kumar AA; Rao MC; Marseille E; Someshwar M; Marshall N; Kahn JG
BMC Public Health; 2005 Sep; 5():98. PubMed ID: 16181491
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
6. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Wilkinson D; Floyd K; Gilks CF
S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
[TBL] [Abstract][Full Text] [Related]
7. The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies.
Menzies NA; Suharlim C; Geng F; Ward ZJ; Brenzel L; Resch SC
BMC Med; 2017 Oct; 15(1):178. PubMed ID: 28982358
[TBL] [Abstract][Full Text] [Related]
8. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
[TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base?
Walker D
Health Policy Plan; 2003 Mar; 18(1):4-17. PubMed ID: 12582104
[TBL] [Abstract][Full Text] [Related]
10. Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India.
Dandona L; Sisodia P; Prasad TL; Marseille E; Chalapathi Rao M; Kumar AA; Kumar SG; Ramesh YK; Over M; Someshwar M; Kahn JG
BMC Health Serv Res; 2005 Nov; 5():69. PubMed ID: 16271151
[TBL] [Abstract][Full Text] [Related]
11. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India.
Dandona L; Sisodia P; Ramesh YK; Kumar SG; Kumar AA; Rao MC; Someshwar M; Hansl B; Marshall N; Marseille E; Kahn JG
Natl Med J India; 2005; 18(1):26-31. PubMed ID: 15835489
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
13. Estimating unbiased economies of scale of HIV prevention projects: a case study of Avahan.
Lépine A; Vassall A; Chandrashekar S; Blanc E; Le Nestour A
Soc Sci Med; 2015 Apr; 131():164-72. PubMed ID: 25779621
[TBL] [Abstract][Full Text] [Related]
14. Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners.
Vassall A; Compernolle P
Health Policy; 2006 Nov; 79(1):1-15. PubMed ID: 16388874
[TBL] [Abstract][Full Text] [Related]
15. The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.
Stover J; Bertozzi S; Gutierrez JP; Walker N; Stanecki KA; Greener R; Gouws E; Hankins C; Garnett GP; Salomon JA; Boerma JT; De Lay P; Ghys PD
Science; 2006 Mar; 311(5766):1474-6. PubMed ID: 16456039
[TBL] [Abstract][Full Text] [Related]
16. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
17. Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31.
Hecht R; Stover J; Bollinger L; Muhib F; Case K; de Ferranti D
Lancet; 2010 Oct; 376(9748):1254-60. PubMed ID: 20934597
[TBL] [Abstract][Full Text] [Related]
18. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
Beck EJ; Santas XM; Delay PR
AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
[TBL] [Abstract][Full Text] [Related]
19. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
Benedikt C; Kelly SL; Wilson D; Wilson DP;
Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
[TBL] [Abstract][Full Text] [Related]
20. HIV prevention cost-effectiveness: a systematic review.
Galárraga O; Colchero MA; Wamai RG; Bertozzi SM
BMC Public Health; 2009 Nov; 9 Suppl 1(Suppl 1):S5. PubMed ID: 19922689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
